Inhalable biohybrid microrobots: a non-invasive approach for lung treatment

Abstract Amidst the rising prevalence of respiratory diseases, the importance of effective lung treatment modalities is more critical than ever. However, current drug delivery systems face significant limitations that impede their efficacy and therapeutic outcome. Biohybrid microrobots have shown co...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhengxing Li, Zhongyuan Guo, Fangyu Zhang, Lei Sun, Hao Luan, Zheng Fang, Jeramy L. Dedrick, Yichen Zhang, Christine Tang, Audrey Zhu, Yiyan Yu, Shichao Ding, Dan Wang, An-Yi Chang, Lu Yin, Lynn M. Russell, Weiwei Gao, Ronnie H. Fang, Liangfang Zhang, Joseph Wang
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-025-56032-4
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832594551412359168
author Zhengxing Li
Zhongyuan Guo
Fangyu Zhang
Lei Sun
Hao Luan
Zheng Fang
Jeramy L. Dedrick
Yichen Zhang
Christine Tang
Audrey Zhu
Yiyan Yu
Shichao Ding
Dan Wang
An-Yi Chang
Lu Yin
Lynn M. Russell
Weiwei Gao
Ronnie H. Fang
Liangfang Zhang
Joseph Wang
author_facet Zhengxing Li
Zhongyuan Guo
Fangyu Zhang
Lei Sun
Hao Luan
Zheng Fang
Jeramy L. Dedrick
Yichen Zhang
Christine Tang
Audrey Zhu
Yiyan Yu
Shichao Ding
Dan Wang
An-Yi Chang
Lu Yin
Lynn M. Russell
Weiwei Gao
Ronnie H. Fang
Liangfang Zhang
Joseph Wang
author_sort Zhengxing Li
collection DOAJ
description Abstract Amidst the rising prevalence of respiratory diseases, the importance of effective lung treatment modalities is more critical than ever. However, current drug delivery systems face significant limitations that impede their efficacy and therapeutic outcome. Biohybrid microrobots have shown considerable promise for active in vivo drug delivery, especially for pulmonary applications via intratracheal routes. However, the invasive nature of intratracheal administration poses barriers to its clinical translation. Herein, we report on an efficient non-invasive inhalation-based method of delivering microrobots to the lungs. A nebulizer is employed to encapsulate picoeukaryote algae microrobots within small aerosol particles, enabling them to reach the lower respiratory tract. Post nebulization, the microrobots retain their motility (~55 μm s-1) to help achieve a homogeneous lung distribution and long-term retention exceeding five days in the lungs. Therapeutic efficacy is demonstrated in a mouse model of acute methicillin-resistant Staphylococcus aureus pneumonia using this pulmonary inhalation approach to deliver microrobots functionalized with platelet membrane-coated polymeric nanoparticles loaded with vancomycin. These promising findings underscore the benefits of inhalable biohybrid microrobots in a setting that does not require anesthesia, highlighting the substantial translational potential of this delivery system for routine clinical applications.
format Article
id doaj-art-69962b8fb7f04f679488e6a65b3a1e0a
institution Kabale University
issn 2041-1723
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj-art-69962b8fb7f04f679488e6a65b3a1e0a2025-01-19T12:30:59ZengNature PortfolioNature Communications2041-17232025-01-0116111310.1038/s41467-025-56032-4Inhalable biohybrid microrobots: a non-invasive approach for lung treatmentZhengxing Li0Zhongyuan Guo1Fangyu Zhang2Lei Sun3Hao Luan4Zheng Fang5Jeramy L. Dedrick6Yichen Zhang7Christine Tang8Audrey Zhu9Yiyan Yu10Shichao Ding11Dan Wang12An-Yi Chang13Lu Yin14Lynn M. Russell15Weiwei Gao16Ronnie H. Fang17Liangfang Zhang18Joseph Wang19Aiiso Yufeng Li Family Department of Chemical and Nano Engineering, University of California San DiegoAiiso Yufeng Li Family Department of Chemical and Nano Engineering, University of California San DiegoAiiso Yufeng Li Family Department of Chemical and Nano Engineering, University of California San DiegoAiiso Yufeng Li Family Department of Chemical and Nano Engineering, University of California San DiegoAiiso Yufeng Li Family Department of Chemical and Nano Engineering, University of California San DiegoAiiso Yufeng Li Family Department of Chemical and Nano Engineering, University of California San DiegoScripps Institution of Oceanography, University of California San DiegoProgram in Materials Science and Engineering, University of California San DiegoAiiso Yufeng Li Family Department of Chemical and Nano Engineering, University of California San DiegoAiiso Yufeng Li Family Department of Chemical and Nano Engineering, University of California San DiegoAiiso Yufeng Li Family Department of Chemical and Nano Engineering, University of California San DiegoAiiso Yufeng Li Family Department of Chemical and Nano Engineering, University of California San DiegoAiiso Yufeng Li Family Department of Chemical and Nano Engineering, University of California San DiegoAiiso Yufeng Li Family Department of Chemical and Nano Engineering, University of California San DiegoAiiso Yufeng Li Family Department of Chemical and Nano Engineering, University of California San DiegoScripps Institution of Oceanography, University of California San DiegoAiiso Yufeng Li Family Department of Chemical and Nano Engineering, University of California San DiegoAiiso Yufeng Li Family Department of Chemical and Nano Engineering, University of California San DiegoAiiso Yufeng Li Family Department of Chemical and Nano Engineering, University of California San DiegoAiiso Yufeng Li Family Department of Chemical and Nano Engineering, University of California San DiegoAbstract Amidst the rising prevalence of respiratory diseases, the importance of effective lung treatment modalities is more critical than ever. However, current drug delivery systems face significant limitations that impede their efficacy and therapeutic outcome. Biohybrid microrobots have shown considerable promise for active in vivo drug delivery, especially for pulmonary applications via intratracheal routes. However, the invasive nature of intratracheal administration poses barriers to its clinical translation. Herein, we report on an efficient non-invasive inhalation-based method of delivering microrobots to the lungs. A nebulizer is employed to encapsulate picoeukaryote algae microrobots within small aerosol particles, enabling them to reach the lower respiratory tract. Post nebulization, the microrobots retain their motility (~55 μm s-1) to help achieve a homogeneous lung distribution and long-term retention exceeding five days in the lungs. Therapeutic efficacy is demonstrated in a mouse model of acute methicillin-resistant Staphylococcus aureus pneumonia using this pulmonary inhalation approach to deliver microrobots functionalized with platelet membrane-coated polymeric nanoparticles loaded with vancomycin. These promising findings underscore the benefits of inhalable biohybrid microrobots in a setting that does not require anesthesia, highlighting the substantial translational potential of this delivery system for routine clinical applications.https://doi.org/10.1038/s41467-025-56032-4
spellingShingle Zhengxing Li
Zhongyuan Guo
Fangyu Zhang
Lei Sun
Hao Luan
Zheng Fang
Jeramy L. Dedrick
Yichen Zhang
Christine Tang
Audrey Zhu
Yiyan Yu
Shichao Ding
Dan Wang
An-Yi Chang
Lu Yin
Lynn M. Russell
Weiwei Gao
Ronnie H. Fang
Liangfang Zhang
Joseph Wang
Inhalable biohybrid microrobots: a non-invasive approach for lung treatment
Nature Communications
title Inhalable biohybrid microrobots: a non-invasive approach for lung treatment
title_full Inhalable biohybrid microrobots: a non-invasive approach for lung treatment
title_fullStr Inhalable biohybrid microrobots: a non-invasive approach for lung treatment
title_full_unstemmed Inhalable biohybrid microrobots: a non-invasive approach for lung treatment
title_short Inhalable biohybrid microrobots: a non-invasive approach for lung treatment
title_sort inhalable biohybrid microrobots a non invasive approach for lung treatment
url https://doi.org/10.1038/s41467-025-56032-4
work_keys_str_mv AT zhengxingli inhalablebiohybridmicrorobotsanoninvasiveapproachforlungtreatment
AT zhongyuanguo inhalablebiohybridmicrorobotsanoninvasiveapproachforlungtreatment
AT fangyuzhang inhalablebiohybridmicrorobotsanoninvasiveapproachforlungtreatment
AT leisun inhalablebiohybridmicrorobotsanoninvasiveapproachforlungtreatment
AT haoluan inhalablebiohybridmicrorobotsanoninvasiveapproachforlungtreatment
AT zhengfang inhalablebiohybridmicrorobotsanoninvasiveapproachforlungtreatment
AT jeramyldedrick inhalablebiohybridmicrorobotsanoninvasiveapproachforlungtreatment
AT yichenzhang inhalablebiohybridmicrorobotsanoninvasiveapproachforlungtreatment
AT christinetang inhalablebiohybridmicrorobotsanoninvasiveapproachforlungtreatment
AT audreyzhu inhalablebiohybridmicrorobotsanoninvasiveapproachforlungtreatment
AT yiyanyu inhalablebiohybridmicrorobotsanoninvasiveapproachforlungtreatment
AT shichaoding inhalablebiohybridmicrorobotsanoninvasiveapproachforlungtreatment
AT danwang inhalablebiohybridmicrorobotsanoninvasiveapproachforlungtreatment
AT anyichang inhalablebiohybridmicrorobotsanoninvasiveapproachforlungtreatment
AT luyin inhalablebiohybridmicrorobotsanoninvasiveapproachforlungtreatment
AT lynnmrussell inhalablebiohybridmicrorobotsanoninvasiveapproachforlungtreatment
AT weiweigao inhalablebiohybridmicrorobotsanoninvasiveapproachforlungtreatment
AT ronniehfang inhalablebiohybridmicrorobotsanoninvasiveapproachforlungtreatment
AT liangfangzhang inhalablebiohybridmicrorobotsanoninvasiveapproachforlungtreatment
AT josephwang inhalablebiohybridmicrorobotsanoninvasiveapproachforlungtreatment